ATE425765T1 - Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen - Google Patents

Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen

Info

Publication number
ATE425765T1
ATE425765T1 AT05425735T AT05425735T ATE425765T1 AT E425765 T1 ATE425765 T1 AT E425765T1 AT 05425735 T AT05425735 T AT 05425735T AT 05425735 T AT05425735 T AT 05425735T AT E425765 T1 ATE425765 T1 AT E425765T1
Authority
AT
Austria
Prior art keywords
medication
oxygen
treatment
collagen
perfluorocarbons
Prior art date
Application number
AT05425735T
Other languages
English (en)
Inventor
Filippo Ernestino Parodi
Franco Papa
Original Assignee
Filippo Ernestino Parodi
Franco Papa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Filippo Ernestino Parodi, Franco Papa filed Critical Filippo Ernestino Parodi
Application granted granted Critical
Publication of ATE425765T1 publication Critical patent/ATE425765T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
AT05425735T 2005-10-20 2005-10-20 Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen ATE425765T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05425735A EP1776960B1 (de) 2005-10-20 2005-10-20 Verwendung von Kollagen in Kombination mit Sauerstoff- und Ozon-freisetzenden Perfluorkohlenwasserstoffen zur Herstellung eines Medikaments zur Behandlung von Hautverletzungen

Publications (1)

Publication Number Publication Date
ATE425765T1 true ATE425765T1 (de) 2009-04-15

Family

ID=36570425

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05425735T ATE425765T1 (de) 2005-10-20 2005-10-20 Verwendung von kollagen in kombination mit sauerstoff- und ozon-freisetzenden perfluorkohlenwasserstoffen zur herstellung eines medikaments zur behandlung von hautverletzungen

Country Status (6)

Country Link
US (1) US20080260787A1 (de)
EP (1) EP1776960B1 (de)
AT (1) ATE425765T1 (de)
DE (1) DE602005013385D1 (de)
ES (1) ES2325274T3 (de)
WO (1) WO2007045982A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2651039C1 (ru) * 2017-04-17 2018-04-18 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Красноярский Государственный Медицинский Университет Имени Профессора В.Ф. Войно-Ясенецкого Министерства Здравоохранения Российской Федерации" Способ местного лечения гнойных ран локальным потоком озоно-кислородной газовой смеси при сахарном диабете ii типа

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789663A (en) * 1984-07-06 1988-12-06 Collagen Corporation Methods of bone repair using collagen
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
IL84911A (en) * 1987-12-22 1993-04-04 Yissum Res Dev Co Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
US5344393A (en) * 1992-02-28 1994-09-06 Alliance Pharmaceutical Corp. Use of synthetic oxygen carriers to facilitate oxygen delivery
US5660857A (en) * 1993-03-22 1997-08-26 Johnson & Johnson Medical Inc. Biopolymer composites
FR2710840B1 (fr) * 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
WO2003082392A2 (en) 2002-03-28 2003-10-09 Exponential Biotherapies, Inc. Oxygenating agents for enhancing host responses to microbial infections
DK1853303T3 (en) * 2005-02-14 2016-02-29 Dpm Therapeutics Corp STABILIZED COMPOSITIONS FOR TOPIC ADMINISTRATION AND PROCEDURES FOR PREPARING IT

Also Published As

Publication number Publication date
ES2325274T3 (es) 2009-08-31
US20080260787A1 (en) 2008-10-23
DE602005013385D1 (de) 2009-04-30
WO2007045982A2 (en) 2007-04-26
EP1776960A1 (de) 2007-04-25
WO2007045982A3 (en) 2007-10-04
EP1776960B1 (de) 2009-03-18

Similar Documents

Publication Publication Date Title
ATE432693T1 (de) Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden
WO2009050506A3 (en) Combination 059
EA200901555A1 (ru) Композиция местного применения по уходу за кожей и способ лечения
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA202091999A2 (ru) Применение ингибиторов dpp iv
BR0308928A (pt) Uso de toxina botulìnica para o tratamento de doenças cardiovasculares, bem como composição para uso em um procedimento cardiovascular
ATE495445T1 (de) Verfahren und zusammensetzungen in verbindung mit morbus alzheimer
CY1117603T1 (el) Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
CY1115617T1 (el) Χρηση της εποθιλονης κατα τη θεραπευτικη αγωγη νοσηματων τα οποια σχετιζονται με την πρωτεϊνη ταu εις τα οποια συμπεριλαμβανεται η νοσος του αlzheimer
ATE449602T1 (de) Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen
FR2969495B1 (fr) Extrait de parties aeriennes de maca riche en polyphenols et composition le comprenant
WO2006018731A3 (fr) Procede d'oxygenotherapie percutanee hyperbare par projection de fluorocarbones
DE602008002252D1 (de) Verwendung hyperbarischer bedingungen zur bereitstellung von neuroprotektion
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
ATE367167T1 (de) Aufbereitung von aldesleukin zur pharmazeutischen verwendung
NO20071238L (no) Fremgangsmater for leging av skader ved human IL-18 administrering
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии
BRPI0512503A (pt) composição que compreende ácido lático e lactoferrina
DE602005013385D1 (de) Verwendung von Kollagen in Kombination mit Sauerstoff- und Ozon-freisetzenden Perfluorkohlenwasserstoffen zur Herstellung eines Medikaments zur Behandlung von Hautverletzungen
ATE527997T1 (de) Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien
EP2216043A4 (de) Verwendung von induktormitteln gse24.2 zur herstellung pharmazeutischer zusammensetzungen zur behandlung von erkrankungen in zusammenhang mit zellseneszenz
WO2011015796A3 (fr) Association d'un rayonnement lumineux et d'un agent de nature peptidique augmentant l'expression d'un substrat de la cytochrome c oxydase pour améliorer notamment l'apparence de la peau et/ou du cheveu
GEP20125638B (en) Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties